Oxidative Phosphorylation Disorders in Diabetes

Oxidative phosphorylation disorders in diabetes involve mitochondrial dysfunction that impairs energy production in cells. High glucose levels can lead to the generation of reactive oxygen species (ROS), which damage mitochondrial DNA and proteins, disrupting ATP synthesis. This impairment exacerbates insulin resistance and contributes to the progression of diabetic complications. Research into antioxidants and mitochondrial-targeted therapies is ongoing, aiming to mitigate oxidative stress and restore cellular energy balance, potentially improving outcomes for individuals with diabetes.